Pantothenic acid — vitamin B5 — derives its name from the Greek word "pantos," meaning "everywhere," reflecting its near-universal distribution in foods. This ubiquity in the diet is matched by its ubiquity in metabolism: pantothenic acid is a structural component of coenzyme A (CoA), one of the most important coenzymes in all of biochemistry. CoA participates in over 100 different metabolic reactions — more than virtually any other coenzyme. Without CoA, the body cannot: synthesize or oxidize fatty acids, run the TCA (Krebs) cycle, synthesize cholesterol, steroid hormones, bile acids, or vitamin D, acetylate drugs and xenobiotics for detoxification, synthesize acetylcholine (a major neurotransmitter), or modify histones to regulate gene expression.
Coenzyme A: structure and function
Coenzyme A is a complex molecule assembled from three components: pantothenic acid (vitamin B5), cysteine (an amino acid), and an ADP moiety (adenosine diphosphate). The biosynthesis of CoA from pantothenic acid requires five enzymatic steps, catalyzed sequentially by: pantothenate kinase (PANK — the rate-limiting enzyme, with four human isoforms), phosphopantothenoylcysteine synthetase (PPCS), phosphopantothenoylcysteine decarboxylase (PPCDC), phosphopantetheine adenylyltransferase (PPAT), and dephospho-CoA kinase (DPCK) (Leonardi et al., 2005, Progress in Lipid Research).
The functional core of CoA is the terminal thiol (-SH) group — derived from cysteine. This reactive sulfhydryl group forms thioester bonds with acyl groups (acetyl, fatty acyl, succinyl, etc.) — creating "activated" metabolic intermediates. The thioester bond has a high free energy of hydrolysis (ΔG ≈ -31.4 kJ/mol) — comparable to ATP hydrolysis — making acyl-CoA esters potent acyl group donors in biosynthetic reactions.
CoA in central carbon metabolism
Acetyl-CoA: the metabolic hub
Acetyl-CoA — a 2-carbon (acetyl) group linked to CoA — is the single most important metabolic intermediate in the body: it is the entry point for fatty acid oxidation products into the TCA cycle; it is the product of pyruvate decarboxylation by the pyruvate dehydrogenase complex (linking glycolysis to the TCA cycle); it is the substrate for: fatty acid synthesis (via malonyl-CoA), cholesterol synthesis (via HMG-CoA), ketone body synthesis, acetylcholine synthesis, and histone acetylation; and its concentration reflects the overall energy status of the cell — when energy is abundant (high acetyl-CoA), biosynthetic pathways are activated; when energy is scarce (low acetyl-CoA), catabolic pathways predominate (Pietrocola et al., 2015, Cell Metabolism).
Succinyl-CoA in the TCA cycle
Succinyl-CoA is a TCA cycle intermediate formed by the α-ketoglutarate dehydrogenase complex — its conversion to succinate (by succinyl-CoA synthetase) generates GTP (substrate-level phosphorylation) and is also required for heme synthesis (δ-aminolevulinic acid synthesis).
Fatty acyl-CoA in lipid metabolism
Long-chain fatty acyl-CoA esters (palmitoyl-CoA, stearoyl-CoA, oleoyl-CoA) are the activated forms of fatty acids required for: β-oxidation (fatty acid breakdown in mitochondria), triglyceride synthesis, phospholipid synthesis, ceramide and sphingolipid synthesis, and protein palmitoylation (post-translational lipid modification affecting protein membrane anchoring and signaling).
Pantothenic acid deficiency
True pantothenic acid deficiency is extremely rare — reflecting the vitamin's widespread distribution in foods and its name ("pantos" = everywhere): historical documentation: during World War II, prisoners of war in Japan and Burma developed a syndrome including burning feet (paresthesias), numbness, and fatigue — later attributed to pantothenic acid deficiency; experimental depletion studies (using the pantothenate kinase inhibitor omega-methylpantothenic acid) produced: fatigue, headache, insomnia, paresthesias in the extremities ("burning feet syndrome"), gastrointestinal disturbances (nausea, abdominal cramps), and impaired antibody production (Hodges et al., 1959, American Journal of Clinical Nutrition).
Pantothenate kinase-associated neurodegeneration (PKAN)
The most dramatic demonstration of pantothenic acid's importance is PKAN (formerly Hallervorden-Spatz disease) — an autosomal recessive neurodegenerative disorder caused by mutations in PANK2 (pantothenate kinase 2 — the mitochondrial isoform): PKAN produces progressive dystonia, spasticity, cognitive decline, and retinitis pigmentosa; MRI shows the characteristic "eye of the tiger" sign — central hyperintensity within hypointense globus pallidus (iron accumulation); the pathophysiology involves: impaired CoA synthesis in mitochondria → cysteine accumulation (cysteine toxicity and iron chelation) → iron deposition in the basal ganglia → neurodegeneration. PKAN demonstrates that even tissue-specific impairment of CoA synthesis produces devastating neurological disease (Gregory et al., 2009, Lancet Neurology).
CoA and epigenetics: histone acetylation
Acetyl-CoA is required for histone acetylation — one of the most important epigenetic modifications: histone acetyltransferases (HATs) transfer acetyl groups from acetyl-CoA to lysine residues on histone tails; acetylation neutralizes the positive charge of lysine → reduces histone-DNA electrostatic interaction → opens chromatin → activates gene transcription; histone deacetylases (HDACs) reverse this modification — removing acetyl groups and compacting chromatin; and the cellular acetyl-CoA pool directly influences the global histone acetylation state — linking metabolic status (via acetyl-CoA) to gene expression (Cai et al., 2011, Molecular Cell).
CoA in drug metabolism
Coenzyme A participates in phase II drug metabolism reactions: acetylation (via N-acetyltransferases using acetyl-CoA) is a major detoxification pathway for: isoniazid (tuberculosis drug), sulfonamide antibiotics, hydralazine, procainamide, and aromatic amines (carcinogen detoxification); and conjugation with CoA is the first step in fatty acid-like metabolism of some xenobiotics. Genetic variation in N-acetyltransferase (NAT) enzymes produces "rapid" and "slow" acetylator phenotypes — affecting drug efficacy, toxicity, and cancer risk from aromatic amines (Hein, 2002, Mutation Research).
Dietary sources and requirements
Pantothenic acid is found in virtually all foods: the richest sources include organ meats (liver — the single richest source), egg yolk, sunflower seeds, shiitake mushrooms, avocado, chicken breast, sweet potato, lentils, and milk. The adequate intake (AI) is 5 mg/day for adults — easily met by most diets. No UL has been established due to the absence of toxicity at high doses. "Royal jelly" (bee product) — which contains exceptionally high pantothenic acid concentrations — has been historically promoted for its vitamin B5 content, though the health claims for royal jelly are largely unsubstantiated (Institute of Medicine, 1998, Dietary Reference Intakes).
Commercial claims: pantothenic acid for acne
Pantothenic acid has been promoted for acne treatment based on the hypothesis that high-dose B5 supplementation enhances CoA-dependent fatty acid oxidation in sebaceous glands → reduces sebum production → reduces acne: Leung (1995, Journal of Orthomolecular Medicine) proposed this mechanism and reported clinical improvement with mega-dose B5 (10 grams/day); a more recent double-blind RCT by Yang et al. (2014, Dermatology and Therapy) found that a proprietary pantothenic acid-based supplement reduced facial acne lesions; however, the evidence base remains limited, the proposed mechanism is speculative, and mega-dose B5 supplementation can cause GI side effects (diarrhea at >10 g/day).
Pantothenic acid is the vitamin that hides in plain sight — everywhere in the diet, everywhere in metabolism, and rarely deficient in anyone eating food. Its importance lies not in supplementation but in understanding its role as the precursor to coenzyme A — one of the most important molecules in all of biochemistry.
CoA and ketone body metabolism
CoA is essential for ketogenesis — the production of ketone bodies during fasting, starvation, or carbohydrate restriction: in the liver, excess acetyl-CoA (from fatty acid oxidation) is condensed to form acetoacetyl-CoA → HMG-CoA → acetoacetate (by HMG-CoA synthase and lyase); acetoacetate is reduced to β-hydroxybutyrate or spontaneously decarboxylated to acetone; ketone bodies are exported to extrahepatic tissues (brain, heart, skeletal muscle) where they are converted back to acetyl-CoA for TCA cycle oxidation; and during prolonged fasting, ketone bodies provide up to 60-70% of the brain's energy needs — replacing the glucose that would otherwise require muscle protein catabolism (gluconeogenesis) to supply (Puchalska & Crawford, 2017, Cell Metabolism).
Pantothenic acid and wound healing
Pantothenic acid and its derivatives have been studied for wound healing applications: dexpanthenol (D-panthenol) — the alcohol analog of pantothenic acid — is widely used in topical wound healing products, moisturizers, and hair care formulations; dexpanthenol is converted to pantothenic acid in the skin → enhances CoA-dependent processes including: epithelial cell migration, collagen synthesis, and fibroblast proliferation; clinical studies have demonstrated that dexpanthenol-containing topical preparations accelerate wound healing, reduce inflammation, and improve skin hydration (Proksch & Nissen, 2002, Skin Pharmacology and Applied Skin Physiology).
CoA and protein acetylation (beyond histones)
Protein acetylation — using acetyl-CoA as the acetyl group donor — extends far beyond histone modification: lysine acetylation is one of the most common post-translational modifications, affecting thousands of proteins; acetylation of metabolic enzymes in mitochondria regulates their activity — responding to the metabolic state of the cell (high acetyl-CoA → increased acetylation → altered enzyme activity); p53 — the "guardian of the genome" tumor suppressor — is regulated by acetylation; and α-tubulin acetylation (in microtubules) regulates cytoskeletal dynamics, intracellular transport, and cell motility (Choudhary et al., 2009, Science).
Pantothenic acid and adrenal function
Pantothenic acid has a historical association with adrenal gland function (hence its older name "anti-stress vitamin"): the adrenal cortex has one of the highest CoA concentrations in the body — reflecting the massive CoA requirement for steroid hormone synthesis (cortisol, aldosterone, and adrenal androgens are all synthesized from cholesterol via CoA-dependent pathways); pantothenic acid deficiency in animals produces adrenal cortex atrophy and impaired corticosteroid production; and the "anti-stress" claim for pantothenic acid supplements is based on this adrenal connection — though no clinical evidence supports supplementation above adequate levels for stress management in humans.
CoA in cholesterol and bile acid synthesis
CoA is essential for cholesterol metabolism: cholesterol synthesis begins with the condensation of two acetyl-CoA molecules → acetoacetyl-CoA → HMG-CoA → mevalonate (the rate-limiting step, catalyzed by HMG-CoA reductase — the target of statin drugs); and cholesterol is eliminated from the body as bile acids — bile acid synthesis in the liver requires CoA for the initial activation step (cholesterol → cholyl-CoA → conjugated bile acids). The statin drug class — the most widely prescribed medications globally — works by inhibiting the CoA-dependent pathway of cholesterol synthesis.
Pantothenic acid is the vitamin that builds coenzyme A — and coenzyme A is the molecule that connects all of metabolism. It is the molecular coupler that links sugar breakdown to fat synthesis, amino acid catabolism to energy production, and acetyl groups to gene regulation. Without pantothenic acid, there is no CoA — and without CoA, there is no metabolism.
CoA pool regulation and metabolic sensing
The cellular CoA pool is tightly regulated and serves as a metabolic sensor: total CoA concentration in the cell (typically 0.02-0.14 mM in the cytoplasm and 2-5 mM in the mitochondrial matrix) determines the flux through CoA-dependent pathways; the ratio of free CoA to acyl-CoA (free CoA/acyl-CoA) reflects the cell's metabolic state: high free CoA/acyl-CoA = energy-depleted state → activates catabolic pathways; low free CoA/acyl-CoA = energy-replete state → favors biosynthetic pathways; pantothenate kinase (PANK) — the rate-limiting enzyme in CoA biosynthesis — is allosterically inhibited by CoA and acyl-CoA → providing feedback regulation; and CoA sequestration in acyl-CoA esters (CoA trapping) can impair metabolic flux — this occurs in fatty acid oxidation disorders where accumulated acyl-CoA esters deplete the free CoA pool → secondary impairment of multiple CoA-dependent pathways (Leonardi et al., 2005, Progress in Lipid Research).
Pantothenic acid in the acyl carrier protein
In addition to CoA, pantothenic acid is a structural component of the acyl carrier protein (ACP) — a component of fatty acid synthase (FAS): ACP contains a 4'-phosphopantetheine prosthetic group — derived from CoA, which in turn derives from pantothenic acid; the 4'-phosphopantetheine arm serves as a flexible tether — attaching growing fatty acid chains to ACP and swinging them between the active sites of fatty acid synthase; ACP is essential for de novo fatty acid synthesis and polyketide synthesis — extending pantothenic acid's metabolic reach beyond CoA-dependent reactions.
Coenzyme A and neurotransmitter synthesis
CoA is directly involved in the synthesis of acetylcholine — one of the most important neurotransmitters: acetyl-CoA + choline → acetylcholine (catalyzed by choline acetyltransferase — ChAT); acetylcholine is essential for: neuromuscular junction signaling (muscle contraction), parasympathetic nervous system function (rest and digest), and cognitive function (memory, attention, learning — cholinergic dysfunction is central to Alzheimer's disease pathology); and the availability of acetyl-CoA in cholinergic neurons may become rate-limiting for acetylcholine synthesis during periods of high neurotransmitter demand — connecting pantothenic acid (→ CoA → acetyl-CoA → acetylcholine) to cognitive function.
Pantethine: the supplemental form
Pantethine (a dimeric form of pantetheine — the CoA precursor) has been studied as a lipid-lowering supplement: clinical trials have found that pantethine (600-900 mg/day) modestly reduces total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol; the mechanism may involve: enhanced CoA-dependent fatty acid β-oxidation in the liver, reduced hepatic cholesterol synthesis (through effects on the HMG-CoA pathway), and improved lipoprotein metabolism; and Rumberger et al. (2011, Nutrition Research) conducted a randomized trial showing that pantethine reduced cardiovascular risk markers in low-to-moderate risk North American adults — though the effect sizes were modest and the evidence base remains limited.
Pantothenic acid and circadian rhythm
Emerging research connects CoA metabolism to circadian biology: CoA levels oscillate with circadian rhythm — reflecting the daily cycling of metabolic activity; NAD⁺-dependent sirtuins (particularly SIRT1 and SIRT3) — which deacetylate histones and metabolic enzymes — link the NAD⁺ cycle to the acetyl-CoA cycle → connecting circadian metabolism to epigenetic regulation; and disruption of CoA metabolism may contribute to the metabolic consequences of circadian disruption (shift work, jet lag) — though this is a speculative but active area of research.
CoA in bacterial and viral pathology
CoA and its derivatives play roles in infectious disease: many pathogenic bacteria synthesize unique CoA-dependent compounds — Mycobacterium tuberculosis produces mycolic acids (complex fatty acids) via CoA-dependent pathways; CoA-dependent acetylation is used by bacteria for: antibiotic resistance (aminoglycoside acetyltransferases acetylate aminoglycoside antibiotics → inactivation), virulence factor modification, and immune evasion; and viral pathogens exploit host cell CoA-dependent pathways: viruses require host cell fatty acid synthesis (CoA-dependent) for membrane assembly, and viral protein myristoylation/palmitoylation (CoA-dependent) is required for viral assembly and budding.
Pantothenic acid and athletic performance
CoA's central role in energy metabolism makes pantothenic acid potentially relevant to exercise: CoA is required for fatty acid oxidation — the primary fuel source during moderate-intensity endurance exercise; CoA is required for TCA cycle flux — essential for sustained aerobic ATP production; and some athletes use pantothenic acid supplements — though no controlled evidence supports enhanced performance beyond what adequate dietary intake provides. The practical recommendation: athletes should ensure adequate B5 intake through a varied diet — but mega-dose supplementation has no proven ergogenic effect.
Pantothenic acid analytical methods
Measuring pantothenic acid status is technically challenging: plasma pantothenic acid levels can be measured by microbiological assay (using Lactobacillus plantarum) or HPLC-MS/MS; blood pantothenic acid levels reflect recent dietary intake more than tissue stores; urinary pantothenic acid excretion may better reflect status — but is affected by renal function and hydration status; and whole blood CoA levels (measured by enzymatic assay) may be the most physiologically relevant measure — but are technically demanding and not widely available clinically.
The CoA-NAD⁺-SAM-FAD metabolic nexus
CoA does not function in isolation — it operates within a metabolic nexus of cofactors: CoA (from pantothenic acid), NAD⁺ (from niacin/tryptophan), FAD (from riboflavin), and SAM (from methionine/folate/B12) together constitute the core cofactor system of intermediary metabolism. Deficiency of any one can impair the function of the others — explaining why B-vitamin deficiencies often co-occur and produce overlapping clinical syndromes. This metabolic nexus — the interconnected cofactor network that drives all of cellular metabolism — represents one of the most beautiful examples of biochemical integration in nature.
Pantothenic acid's name says it all — it is everywhere. In every food, in every cell, in every metabolic pathway that involves an acyl group transfer. Its coenzyme — CoA — is one of the most frequently written abbreviations in biochemistry, appearing in the TCA cycle, fatty acid metabolism, amino acid catabolism, steroid synthesis, neurotransmitter production, and gene regulation. It is, quite simply, one of the molecules that makes metabolic life possible.
Pantothenic acid in complete nutrition
In the broader context of nutrition, pantothenic acid exemplifies the concept that essential nutrients work as integrated systems rather than isolated molecules: CoA requires pantothenic acid, cysteine, and ATP for its synthesis — connecting B5 to sulfur amino acid metabolism and energy metabolism; CoA function requires riboflavin (FAD in the electron transport chain and fatty acid oxidation), niacin (NAD⁺ as electron acceptor), and thiamine (pyruvate dehydrogenase complex); and the metabolic outputs of CoA-dependent reactions (acetyl groups for histone acetylation, fatty acids for membrane synthesis, steroids for hormonal regulation) affect virtually every aspect of human physiology. No nutrient is an island — and pantothenic acid, more than most, illustrates the interconnectedness of nutritional biochemistry.
Pantothenic acid proves that the most essential molecules are often the most invisible — present everywhere, required by everything, and noticed only in their rare absence. CoA is the universal metabolic coupler — the molecule that links all of intermediary metabolism into a single, integrated, breathtaking whole.